Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
4.070
-0.620 (-13.22%)
At close: Jul 31, 2026, 4:00 PM EDT
4.090
+0.020 (0.49%)
After-hours: Jul 31, 2026, 7:59 PM EDT
Iovance Biotherapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Reiterates $11 | Buy | Reiterates | $11 | +170.27% | Jul 20, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $10 | Buy | Maintains | $10 | +145.70% | Jun 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $9 | Buy | Reiterates | $9 | +121.13% | Jun 4, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $14 | Buy | Reiterates | $14 | +243.98% | May 8, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $5 | Buy | Maintains | $5 | +22.85% | May 7, 2026 |
| UBS | UBS | Hold Reiterates $2 → $4 | Hold | Reiterates | $2 → $4 | -1.72% | Mar 5, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $14 | Buy | Reiterates | $14 | +243.98% | Feb 26, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | -1.72% | Feb 25, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.